What Matters More In DNA-Encoded Libraries: Size, Quality, Or Chemical Diversity?

DNA-encoded libraries (DELs) have transformed early drug discovery by enabling researchers to screen billions of chemical compounds in a single experiment. While scale often dominates the discussion around DELs, the true differentiator lies in the quality of the library itself. As Dr. Ying Zhang of X-Chem explains, a well‑designed DEL doesn’t just broaden chemical diversity—it strengthens the reliability of screening results and guides more confident decision‑making during hit identification and validation. Thoughtful library design can ultimately influence which compounds advance, shaping the trajectory of discovery programs from the start. For teams relying on DELs to uncover novel therapeutics, understanding what defines a high-quality library is essential.

Explore how strategic design impacts data clarity, compound progression, and overall discovery success.